BioCentury
ARTICLE | Clinical News

AMT-030 regulatory update

April 30, 2012 7:00 AM UTC

The European Commission granted Orphan Drug designation for AMT-030 from uniQure to treat primary hyperoxaluria type 1. AMT-030 is in preclinical testing, with clinical testing expected to start in 3 ...